What is the management approach for patients with known blebs (bullae)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Pulmonary Blebs and Bullae

Primary Recommendation

For asymptomatic patients with incidentally detected blebs or bullae on imaging, observation without intervention is appropriate, as these findings are remarkably common in the general population (present in approximately 33.8% of adults without lung disease) and do not reliably predict pneumothorax occurrence. 1

Clinical Context and Surveillance Strategy

Understanding the Natural History

  • Blebs and bullae are found in 80-90% of patients who develop primary spontaneous pneumothorax at thoracoscopy or CT scanning, yet they are also present in one-third of the normal population without any clinical consequences 2, 1
  • The presence of blebs/bullae on high-resolution CT (HRCT) does significantly increase the risk of ipsilateral pneumothorax recurrence (68.1% vs 6.1% in those without such findings) if a first pneumothorax has already occurred 3
  • In asymptomatic individuals, incidentally detected blebs and bullae show no evidence of rupture during extended follow-up periods (mean 1,531 days), even in high-risk occupations like fast jet pilots 4

Imaging Characteristics to Document

  • Size classification: Blebs are typically <1-2 cm and subpleural; bullae are >2 cm in diameter 2, 5
  • Location: Most blebs and bullae are confined to the lung apices 6
  • Bilaterality: When present, these lesions are commonly bilateral (78.6% of cases) 6
  • Distinguish from normal variants: "Apical lines" on CT are seen in 28% of normal controls and should not be confused with true blebs 6

Management Algorithm Based on Clinical Presentation

For Asymptomatic Patients with Incidental Findings

No intervention is required. 4, 1

  • Routine follow-up imaging is not necessary for stable, small blebs/bullae in asymptomatic individuals 4
  • Even in high-risk occupations (pilots, including fast jet aircraft), preventive surgical treatment is not recommended for incidentally detected lesions in adults ≥40 years without underlying lung disease 4
  • Smoking cessation counseling is critical, as smoking increases lifetime pneumothorax risk to 12% in men versus 0.1% in non-smokers 2

For Patients After First Pneumothorax Episode

HRCT imaging should be obtained to assess for blebs/bullae, as this significantly stratifies recurrence risk. 3

  • Patients with blebs/bullae on HRCT have a 68.1% risk of ipsilateral recurrence versus 6.1% without such findings (negative predictive value 93.9%) 3
  • Contralateral pneumothorax risk is 19% with blebs/bullae versus 0% without them 3
  • The dystrophic severity score (based on number and distribution of lesions) correlates with recurrence risk up to 75% in patients with bilateral multiple lesions 3

Indications for Surgical Referral

Surgical consultation should be obtained for: 2

  • Second ipsilateral pneumothorax
  • First contralateral pneumothorax
  • Synchronous bilateral spontaneous pneumothorax
  • Persistent air leak despite 5-7 days of chest tube drainage
  • First pneumothorax in high-risk professions (pilots, divers) where even a single recurrence poses unacceptable risk 2
  • Pregnancy 2

Surgical Approach When Indicated

Video-assisted thoracoscopic surgery (VATS) with bullectomy and surgical pleurodesis is the preferred approach for most patients. 2

  • VATS offers reduced hospital stay, less postoperative pain, and fewer complications compared to open thoracotomy 2
  • The operation should include both resection of visible blebs/bullae (bullectomy using stapler equipment) and surgical pleurodesis (via pleural abrasion, partial pleurectomy, or talc poudrage) to obliterate the pleural space 2
  • For the lowest recurrence risk required in specific high-risk occupations, thoracotomy with surgical pleurodesis should be considered, as VATS has 5-10% recurrence rates versus 1% for open procedures 2

Special Populations and Considerations

Diving Medicine

  • Diving should be permanently discouraged after any pneumothorax unless a very secure definitive prevention strategy such as surgical pleurectomy has been performed 2
  • The high prevalence of blebs/bullae in the normal population (33.8%) does not justify preventive surgery in asymptomatic divers, but any pneumothorax occurrence mandates permanent cessation or definitive surgical intervention 2, 1

Air Travel Restrictions

  • Patients should not fly commercially until 6 weeks after definitive surgical procedure or complete radiographic resolution of pneumothorax 2
  • There remains significant recurrence risk for up to 1 year after pneumothorax, particularly in secondary spontaneous pneumothorax 2

Common Pitfalls to Avoid

  • Do not perform prophylactic surgery based solely on CT findings of blebs/bullae in asymptomatic patients, as these are common normal variants 4, 1
  • Do not confuse apical lines with true blebs on CT imaging—apical lines are seen in 28% of normal controls and represent a normal variant 6
  • Do not rely on chest radiography alone to detect blebs/bullae, as CT is far superior (detecting lesions in 80% of cases versus only 31% on plain films) 5
  • Do not assume size or number of blebs/bullae predicts early recurrence after conservative treatment of first pneumothorax—no correlation exists for early recurrences 5
  • Do not delay surgical referral beyond 5-7 days for persistent air leak, as prolonged conservative management increases morbidity without improving outcomes 2

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.